title: 'Just a repeat' - When drug monitoring is indicated.
abstract: BACKGROUND
  Therapeutic drug monitoring, the measurement of plasma or blood concentrations of a medication to assist the management of patients, is commonly performed by general practitioners and specialists alike. However, established therapeutic ranges are only available for a limited number of medications.
  
  
  OBJECTIVE
  This article outlines the basics of therapeutic drug monitoring,including the drugs for which monitoring is suitable and when, how and why it should be performed in general practice.
  
  
  CONCLUSIONS
  Therapeutic drug monitoring is generally only indicated when medications have specific characteristics (eg. a narrow therapeutic index), where there is an established therapeutic range, where the consequences of undertreatment cannot be recognised clinically and can be serious (eg. seizure) and/or if toxicity is suspected. Commonly used medications where therapeutic drug monitoring is indicated include some antiepileptic drugs (eg. phenytoin, carbamazepine), lithium and digoxin. For the majority of medications, therapeutic drug monitoring is unlikely to assist management and should not be performed.
authors.affiliation: Department of Clinical Pharmacology, Royal Brisbane and Women's Hospital, Brisbane, Queensland. catherine_lucas@health.qld.gov.au
authors.forename: Catherine
authors.initials: C
authors.lastname: Lucas
authors.forename: Peter
authors.initials: P
authors.lastname: Donovan
mesh_terms: D000927:Anticonvulsants / Q000097:blood; D018692:Antimanic Agents / Q000097:blood; D002316:Cardiotonic Agents / Q000097:blood; D004077:Digoxin / Q000097:blood; D016903:Drug Monitoring / Q000379:methods*; D058006:General Practice / Q000379:methods; D006801:Humans; D008094:Lithium / Q000097:blood
chemical_list: D000927:Anticonvulsants; D018692:Antimanic Agents; D002316:Cardiotonic Agents; D004077:Digoxin; D008094:Lithium